I agree that this site is using cookies. You can find further informations here.
X
Ferrucci, Pier Francesco
315  results:
Search for persons X
?
1

Corrigendum to "Nivolumab plus ipilimumab in melanoma patie..:

Di Giacomo, Anna Maria ; Chiarion-Sileni, Vanna ; Del Vecchio, Michele...
European Journal of Cancer.  202 (2024)  - p. 113981 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Correction: Efficacy and Safety of the Melphalan/Hepatic De..:

Zager, Jonathan S. ; Orloff, Marlana ; Ferrucci, Pier Francesco...
Annals of Surgical Oncology.  , 2024
Link: https://doi.org/10.1245/..
 
?
3

Sequential immunotherapy and targeted therapy for metastati..:

Ascierto, Paolo A. ; Casula, Milena ; Bulgarelli, Jenny...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepat..:

Zager, Jonathan S. ; Orloff, Marlana ; Ferrucci, Pier Francesco...
Annals of Surgical Oncology.  31 (2024)  8 - p. 5220-5221 , 2024
Link: https://doi.org/10.1245/..
 
?
5

Efficacy and Safety of the Melphalan/Hepatic Delivery Syste..:

Zager, Jonathan S. ; Orloff, Marlana ; Ferrucci, Pier Francesco...
Annals of Surgical Oncology.  31 (2024)  8 - p. 5340-5351 , 2024
Link: https://doi.org/10.1245/..
 
?
6

Nivolumab plus ipilimumab in melanoma patients with asympto..:

Di Giacomo, Anna Maria ; Chiarion-Sileni, Vanna ; Del Vecchio, Michele...
European Journal of Cancer.  199 (2024)  - p. 113531 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Cancer immunity and immunotherapy beyond COVID-19:

Bellone, Matteo ; Brevi, Arianna ; Bronte, Vincenzo...
Cancer Immunology, Immunotherapy.  , 2023
Link: https://doi.org/10.1007/..
 
?
8

Actionable Genetic Screens Unveil Targeting of AURKA, MEK, ..:

Marocchi, Federica ; Palluzzi, Fernando ; Nicoli, Paola...
Journal of Investigative Dermatology.  143 (2023)  10 - p. 1993-2006.e10 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian networ..:

Bellone, Matteo ; Brevi, Arianna ; Bronte, Vincenzo...
Cancer Immunology, Immunotherapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
10

KEYNOTE-022: Pembrolizumab with trametinib in patients with..:

Maio, Michele ; Carlino, Matteo S. ; Joshua, Anthony M....
European Journal of Cancer.  160 (2022)  - p. 1-11 , 2022
Link: https://doi.org/10.1016/..
 
?
11

KEYNOTE – D36: Personalized Immunotherapy with a Neoepitope..:

Long, Georgina V ; Ferrucci, Pier Francesco ; Khattak, Adnan...
Future Oncology.  18 (2022)  31 - p. 3473-3480 , 2022
Link: https://doi.org/10.2217/..
 
?
12

Differential activity of avapritinib in patients with metas..:

Corti, Chiara ; Conforti, Fabio ; Pala, Laura...
European Journal of Cancer.  172 (2022)  - p. 332-339 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer I..:

Ferrucci, Pier Francesco ; Pala, Laura ; Conforti, Fabio.
Cancers.  13 (2021)  6 - p. 1383 , 2021
Link: https://doi.org/10.3390/..
 
?
14

Novel Biomarkers and Druggable Targets in Advanced Melanoma:

Ferrucci, Pier Francesco ; Cocorocchio, Emilia
Cancers.  14 (2021)  1 - p. 81 , 2021
Link: https://doi.org/10.3390/..
 
?
15

Vitamin D Supplementation and Disease-Free Survival in Stag..:

Johansson, Harriet ; Spadola, Giuseppe ; Tosti, Giulio...
Nutrients.  13 (2021)  6 - p. 1931 , 2021
Link: https://doi.org/10.3390/..
 
1-15